Product Information
CHLOROQUINE PH 500 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $6.6539 per EA under NDC 64980017802. Its NADAC has been published 367 times since Nov 28, 2013.
FDA first approved this application on Jan 21, 2011. Its Orange Book therapeutic-equivalence code is AA.
Strength
500 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980017802
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLOROQUINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA090612FDA Approved
1/21/2011
TE Code
AA
On Market Since
7/1/2011
Pharmacological Classes
Price Statistics
The NADAC for CHLOROQUINE PH 500 MG TABLET has been published 367 times since Nov 28, 2013, and over the history we have for it it has risen 228.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6539 per EA |
|---|---|
| All-time high | $11.1302 (Aug 16, 2017) |
| All-time low | $1.4374 (Nov 19, 2014) |
| 52-week high | $6.7412 |
| 52-week low | $5.7554 |
| Median price | $5.7554 |
| Average price | $6.0429 |
| Largest weekly change | +370.4% (May 18, 2016) |
| Weeks tracked | 367 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chloroquine Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLOROQUINE PH 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLOROQUINE PH 500 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $6.6539 per EA (NDC 64980017802), effective Sep 30, 2026.
How has the price of CHLOROQUINE PH 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLOROQUINE PH 500 MG TABLET has risen 228.8%. It has been tracked across 367 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHLOROQUINE PH 500 MG TABLET?
Since Nov 28, 2013, the NADAC for CHLOROQUINE PH 500 MG TABLET has ranged from a low of $1.4374 (Nov 19, 2014) to a high of $11.1302 (Aug 16, 2017), with a median of $5.7554 per EA.
Are there cheaper alternatives to CHLOROQUINE PH 500 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHLOROQUINE PH 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLOROQUINE PH 500 MG TABLET?
CHLOROQUINE PH 500 MG TABLET (NDC 64980017802) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.